Proteome Sciences – emphasises “strong development” including increased “cash reserves”. Er, what about those borrowings?!Describing itself as “a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification”, Proteome Sciences (PRM) has issued a trading update commencing that it “is pleased to report that it has continued to show strong growth” and concluding that the “business is strongly positioned for 2023”. So what of a current more than 22% higher share price response to 4.6p?
- By Steve Moore
- 2023-02-20 14:27:42